BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 30

• Drug Development

  Tyrogenex, Inc. Presents Final Results From Phase 1 Study Of X-82 For Wet AMD At The 2015 Annual American Academy of Ophthalmology Meeting

  November 16, 2015

   · 

  3 min read
• Drug Development

  Ohr Pharma Presents New Data From OHR-102 Phase II IMPACT Study In Wet-AMD At American Academy of Ophthalmology Annual Meeting

  November 16, 2015

   · 

  5 min read
• Drug Development

  VBL Therapeutics Data On VB-111 In Combination With Bevacizumab To Be Presented At The Annual Meeting Of The Society For Neuro-Oncology

  November 16, 2015

   · 

  4 min read
• Pharm Country

  Mesoblast Lists On Nasdaq

  November 16, 2015

   · 

  2 min read
• Drug Development

  CymaBay Therapeutics Announces Participation At Three Upcoming Investor Conferences

  November 16, 2015

   · 

  1 min read
• Genetown

  Minerva Neurosciences, Inc. To Present At Jefferies and Co. 2015 London Healthcare Conference On November 18, 2015

  November 16, 2015

   · 

  1 min read
• Mylan Launches Generic GLUCOTROL XL Tablets

  November 16, 2015

   · 

  1 min read
• Biotech Bay

  BeBop Will Demonstrate Latest Wearables, IoT, Medical, Automotive & Robotics Market Innovations at Leading Silicon Valley Wearable Tech Conference

  November 16, 2015

   · 

  3 min read
• Business

  Xenetic Biosciences Enters Into Asset Purchase Agreement With Financing Component For The Rights To Develop, Market And License Oncologic Drug Candidate Virexxa™

  November 16, 2015

   · 

  5 min read
• Business

  NovaBay Reschedules Third Quarter 2015 Conference Call To November 19

  November 16, 2015

   · 

  1 min read